Our Clinical Publications

MR-guided SABR in oligometastatic liver disease

Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysis

MR-guided adaptive radiotherapy (SMART)

Salvage stereotactic MR-guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes

Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer:

First Reported Clinical Outcomes From the UK

Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer

Protocol summary of the Emerald- Pancreas phase 1/expansion study located at Oxford University Hospital, UK

Stereotactic Magnetic Resonance−Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer

Acute and Late Patient-Reported Toxicity Outcomes

Phase 3 trial of SABR in localised prostate cancer

(PACE B)